Senior Director, US Medical Director – Multiple Myeloma

Job Description

Reports to: Vice President, US Medical Affairs (or equivalent)

Direct Reports: Director, Medical Strategy – Multiple Myeloma Additional disease-area or program roles as the portfolio expands

Role Purpose

The Senior Director, US Medical Director – Multiple Myeloma (MM) serves as the US medical leader for the Multiple Myeloma franchise, accountable for end-to-end medical strategy, scientific leadership, and evidence execution across the lifecycle of the MM portfolio.

This role sets the US medical vision for MM, translates global scientific strategy into US-specific medical priorities, and ensures medical affairs is a credible, high-impact partner to clinical development, commercial, market access, and external stakeholders.

Key Responsibilities

• Own and lead the US Medical Affairs strategy for Multiple Myeloma, ensuring alignment with portfolio vision, partnering with global team for lifecycle planning, and evolving treatment paradigms.
• Serve as the primary US medical voice for MM across internal governance forums and senior leadership discussions.
• Provide medical leadership across launch readiness, post-launch optimization, and indication expansion.
• Partner with the global teams (Global Strategy & Evidence Generation) to create an integrated evidence generation strategy for MM, including ISR, RWE, HEOR, publications, and congress planning.
• Ensure scientific narratives are medically rigorous, clinically relevant, and aligned to unmet patient and HCP needs.
• Guide interpretation of emerging data and competitive intelligence to inform proactive medical strategy adjustments.
• Act as a senior medical partner to Commercial, Market Access, Clinical Development, Regulatory, and Global Medical Affairs.
• Ensure strong medical input into brand strategy, segmentation, and external engagement strategy, while maintaining clear non-promotional boundaries.
• Represent US Medical Affairs in global forums, ensuring US insights are incorporated into global strategy.
• Partner with internal medical affairs headquarters team & field medical leadership & team
• Oversee Access, OOS & EAP Oversight
• Provide strategic oversight and governance for Out-of-Specification (OOS) and Expanded Access Program (EAP) medical activities within MM.
• Ensure ethical, compliant, and patient-focused execution of access programs aligned with company policies and regulatory expectations.
• People & Organizational Leadership
• Build, lead, and develop a high-performing MM medical team, including direct management of the Director, Medical Strategy and OOS/EAP Manager.
• Set clear priorities, decision rights, and success metrics across the MM medical organization.
• Actively coach and mentor leaders to grow strategic capability, medical judgment, and enterprise mindset.

Qualifications

• MD, PharmD, PhD, or equivalent advanced scientific/clinical degree
• 12+ years of experience in Medical Affairs within biopharma, including hematology/oncology
• Demonstrated experience leading franchise-level medical strategy
• Proven people leadership experience

Preferred

• Multiple Myeloma expertise
• Experience supporting cell therapy or complex specialty launches
• Experience navigating access programs, managed access, or EAP/OOS processes

Leadership Competencies

• Enterprise medical leadership
• Ability to work in a matrix organization / highly adaptable mindset
• Strategic thinking and decision-making
• Strong communication & presentation skills
• Scientific credibility and influence
• Talent development and culture building
• Executive presence and cross-functional impact

Benefits

The salary range for this position is: Bay Area: $281,010.00 - $363,660.00. Other US Locations: $255,425.00 - $330,550.00. Kite considers a variety of factors when determining base compensation, including experience, qualifications, and geographic location. These considerations mean actual compensation will vary.

This position may also be eligible for a discretionary annual bonus, discretionary stock-based long-term incentives (eligibility may vary based on role), paid time off, and a benefits package.

Benefits include company-sponsored medical, dental, vision, and life insurance plans*. For additional benefits information, visit: https://www.gilead.com/careers/compensation-benefits-and-wellbeing

Kite is a biopharmaceutical company engaged in the development of innovative cancer immunotherapies with a goal of providing rapid, long-term durable response and eliminating the burden of chronic care. The company is focused on chimeric antigen receptor (CAR) and T cell receptor (TCR) engineered cell therapies designed to empower the immune system's ability to recognize and kill tumors. Kite is based in Santa Monica, CA. For more information on Kite, please visit www.kitepharma.com.